Despite their potential, prodrugs also face several challenges. These include the complexity of design and synthesis, the need for precise control over their conversion to active forms, and potential differences in enzyme expression among patients. Additionally, unpredictable interactions with other medications or variations in metabolic pathways can impact the efficacy and safety of prodrugs.
